Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. (Q51382786)
Jump to navigation
Jump to search
scientific article published in March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. |
scientific article published in March 2011 |
Statements
1 reference
Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. (English)
1 reference
A H Barnett
1 reference
H Huisman
1 reference
D Neubacher
1 reference
H-J Woerle
1 reference
K A Dugi
1 reference
1 March 2011
1 reference
13
1 reference
258-267
1 reference
3
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference